Skip to Content

1,321 Results Found

  • Review
  • Open Access
22 Citations
6,036 Views
17 Pages

Intrauterine Hypoxia and Epigenetic Programming in Lung Development and Disease

  • Yajie Tong,
  • Shuqing Zhang,
  • Suzette Riddle,
  • Lubo Zhang and ,
  • Rui Song and
  • Dongmei Yue
  • + 1 author+ 0 author

Clinically, intrauterine hypoxia is the foremost cause of perinatal morbidity and developmental plasticity in the fetus and newborn infant. Under hypoxia, deviations occur in the lung cell epigenome. Epigenetic mechanisms (e.g., DNA methylation, hist...

(This article belongs to the Special Issue MicroRNAs, tRNA Fragments, and Circular RNAs: Pivotal Regulators of Gene Expression and Their Roles in Human Diseases)
  • Review
  • Open Access
11 Citations
1,929 Views
8 Pages

Uncontrolled Donation after Circulatory Death Only Lung Program: An Urgent Opportunity

  • Chiara Lazzeri,
  • Manuela Bonizzoli,
  • Simona Di Valvasone and
  • Adriano Peris

12 October 2023

Uncontrolled donation after circulatory death (uDCD) represents a potential source of lungs, and since Steen’s 2001 landmark case in Sweden, lungs have been recovered from uDCD donors and transplanted to patients in other European countries (Fr...

(This article belongs to the Section Emergency Medicine)
  • Review
  • Open Access
14 Citations
4,302 Views
11 Pages

Immunonutrition, Metabolism, and Programmed Cell Death in Lung Cancer: Translating Bench to Bedside

  • Palma Fedele,
  • Anna Natalizia Santoro,
  • Francesca Pini,
  • Marcello Pellegrino and ,
  • Giuseppe Polito,
  • Maria Chiara De Luca,
  • Antonietta Pignatelli,
  • Michele Tancredi,
  • Valeria Lagattolla and
  • Pietro Bracciale
  • + 8 authors+ 3 authors

4 June 2024

Lung cancer presents significant therapeutic challenges, motivating the exploration of novel treatment strategies. Programmed cell death (PCD) mechanisms, encompassing apoptosis, autophagy, and programmed necrosis, are pivotal in lung cancer pathogen...

(This article belongs to the Special Issue Cell Self-Destruction (Programmed Cell Death), Immunonutrition and Metabolism)
  • Article
  • Open Access
7 Citations
2,597 Views
15 Pages

A Cross-Sectional Study on the Acceptability of Implementing a Lung Cancer Screening Program in Belgium

  • Paloma Diab Garcia,
  • Annemiek Snoeckx,
  • Jan P. Van Meerbeeck and
  • Guido Van Hal

31 December 2022

Lung cancer is the most common and deadliest cancer in the world, and its incidence is expected to grow. Nonetheless, this growth can be contained through smoking cessation programs and effective lung cancer screening programs. In 2018, Belgium had t...

(This article belongs to the Special Issue Advances in Thoracic Oncology)
  • Article
  • Open Access
15 Citations
4,436 Views
11 Pages

The Co-Expression of Programmed Death-Ligand 1 (PD-L1) in Untreated EGFR-Mutated Metastatic Lung Adenocarcinoma

  • Ping-Chih Hsu,
  • Chih-Wei Wang,
  • Scott Chih-Hsi Kuo,
  • Shu-Min Lin and ,
  • Yu-Lun Lo,
  • Allen Chung-Cheng Huang,
  • Li-Chung Chiu and
  • Cheng-Ta Yang
  • + 3 authors+ 0 author

Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) is the standard first-line therapy for metastatic lung adenocarcinoma harboring sensitive EGFR mutations. Tumor surface programmed death-ligand 1 (PD-L1) is expressed in some met...

(This article belongs to the Section Cancer Biology and Oncology)
  • Article
  • Open Access
22 Citations
5,246 Views
18 Pages

Immunophenotype of T Cells Expressing Programmed Death-1 and Cytotoxic T Cell Antigen-4 in Early Lung Cancer: Local vs. Systemic Immune Response

  • Iwona Kwiecien,
  • Tomasz Skirecki,
  • Małgorzata Polubiec-Kownacka,
  • Agata Raniszewska and
  • Joanna Domagala-Kulawik

21 April 2019

The overexpression of programmed death-1 (PD-1) and cytotoxic T cell antigen 4 (CTLA-4) receptors on T cells are among the major mechanisms of tumor immunoevasion. However, the expression pattern of these receptors on T cell subpopulations of a diffe...

(This article belongs to the Special Issue Signaling Pathways and Immune Checkpoint Regulation in Cancer)
  • Article
  • Open Access
1 Citations
2,080 Views
20 Pages

Insights from a Patient-Centered Lung Cancer Navigation Program in a Low-Resource Community

  • Tanyanika Phillips,
  • Anjaney Kothari,
  • Africa Robison,
  • Jeffrey Mark Erfe and
  • Dan J. Raz

1 September 2025

Barriers to cancer care, including transportation and Internet insecurity, are of special concern in low-resource communities. A patient-centered, telehealth-based, barrier-focused lay navigator program may mitigate such barriers. We share insights f...

(This article belongs to the Section Thoracic Oncology)
  • Article
  • Open Access
4 Citations
4,185 Views
19 Pages

7 August 2024

Machine learning (ML) is commonly used to develop survival-predictive radiomic models in non-small cell lung cancer (NSCLC) patients, which helps assist treatment decision making. Radiomic features derived from computer tomography (CT) lung images ai...

(This article belongs to the Special Issue Computational Approaches for Cancer Research)
  • Article
  • Open Access
2 Citations
2,986 Views
15 Pages

Optimizing Lung Cancer Diagnostics: Insights from a Fast-Track Program in a Complex Healthcare Setting

  • Paolo Scanagatta,
  • Alessandro Bertolini,
  • Giuseppe Naldi,
  • Francesca Antoniazzi and ,
  • Francesco Inzirillo,
  • Casimiro Eugenio Giorgetta,
  • Eugenio Ravalli,
  • Gianluca Ancona,
  • Sara Cagnetti and
  • Fabiano Stangoni
  • + 6 authors+ 1 author

25 February 2025

Lung cancer remains a leading cause of cancer-related mortality, with diagnostic delays significantly impacting patient outcomes. Despite advancements in diagnostic strategies, inefficiencies persist, particularly in geographically complex regions wi...

(This article belongs to the Special Issue Innovations in Thoracic Surgery and Medicine: Advancements and Challenges)
  • Article
  • Open Access
8 Citations
3,642 Views
17 Pages

Characterizing Variability in Lung Cancer Outcomes and Influence of a Lung Diagnostic Assessment Program in Southeastern Ontario, Canada

  • Shahad AlGhamdi,
  • Weidong Kong,
  • Michael Brundage,
  • Elizabeth A. Eisenhauer and ,
  • Christopher M. Parker and
  • Geneviève C. Digby
  • + 1 author+ 0 author

9 May 2023

Introduction: Regional variability in lung cancer (LC) outcomes exists across Canada, including in the province of Ontario. The Lung Diagnostic Assessment Program (LDAP) in southeastern (SE) Ontario is a rapid-assessment clinic that expedites the man...

(This article belongs to the Section Thoracic Oncology)
  • Article
  • Open Access
1 Citations
3,037 Views
14 Pages

Programmed Cell Death-Ligand 1 Expression and Clinical Outcomes Among Patients with Resected, Early-Stage Non-Small Cell Lung Cancer: A Real-World Study

  • Parneet K. Cheema,
  • Iqra Syed,
  • Femida Gwadry-Sridhar,
  • Muhammad Rakibuz-Zaman and ,
  • Robin Sachdeva,
  • Alec Pencz,
  • Luna Zhan,
  • Katrina Hueniken,
  • Devalben Patel and
  • M. Sara Kuruvilla
  • + 13 authors+ 8 authors

31 October 2024

Treatment options for non-small cell lung cancer (NSCLC) are evolving, given recent and expected approvals of immune checkpoint inhibitors (ICIs) targeting programmed cell death-(ligand) 1 (PD-1/PD-L1). We retrospectively evaluated outcomes among pat...

  • Study Protocol
  • Open Access
1,837 Views
21 Pages

Project SWITCH Study Protocol: A Tobacco-Free Workplace Program for Dissemination and Implementation in Lung Cancer Screening Centers

  • Ammar D. Siddiqi,
  • Maggie Britton,
  • Isabel Martinez Leal,
  • Matthew Taing and ,
  • Tzuan A. Chen,
  • Lisa M. Lowenstein,
  • Jennifer A. Minnix and
  • Lorraine R. Reitzel
  • + 3 authors+ 0 author

Background/Objectives: Cigarette smoking has been causally linked to 90% of all cases of lung cancer, contributing to its high mortality rate. Lung cancer screening centers offer low-dose computed tomography, the only recommended diagnostic screening...

(This article belongs to the Section Public Health Research)
  • Brief Report
  • Open Access
5 Citations
2,182 Views
8 Pages

Texture Features of 18F-Fluorodeoxyglucose Positron Emission Tomography for Predicting Programmed Death-Ligand-1 Levels in Non-Small Cell Lung Cancer

  • Takashi Norikane,
  • Mariko Ishimura,
  • Katsuya Mitamura,
  • Yuka Yamamoto and ,
  • Hanae Arai-Okuda,
  • Yuri Manabe,
  • Mitsumasa Murao,
  • Riku Morita,
  • Takafumi Obata and
  • Yoshihiro Nishiyama
  • + 8 authors+ 3 authors

12 March 2024

Background: Identifying programmed death-ligand-1 (PD-L1) expression is crucial for optimizing treatment strategies involving immune checkpoint inhibitors. However, the role of intratumoral metabolic heterogeneity specifically derived from 18F-fluoro...

(This article belongs to the Section Respiratory Medicine)
  • Article
  • Open Access
661 Views
12 Pages

Effectiveness of a Telemedicine Exercise Program to Improve Lung Function in Young Adults After COVID-19: A Pilot Study

  • Eyckle C. H. Wong,
  • Raymond W. M. Lo,
  • Rachel L. C. Kwan,
  • Natalie N. M. Chan and ,
  • Sara W. Y. Lam,
  • Ruby Y. K. Ng,
  • Suyi K. C. Wong and
  • Grace P. Y. Szeto
  • + 3 authors+ 0 author

Background: COVID-19 can have adverse effects on individuals’ lung functions for up to 6 months or more after the episode. As a result, people may be reluctant to exercise, and this can have further adverse effects on their lung capacity and fi...

(This article belongs to the Special Issue Innovations in Primary and Community Care for Rehabilitation)
  • Article
  • Open Access
7 Citations
3,234 Views
12 Pages

Cost-Effectiveness of an Organized Lung Cancer Screening Program for Asbestos-Exposed Subjects

  • Sébastien Gendarme,
  • Jean-Claude Pairon,
  • Pascal Andujar,
  • François Laurent and ,
  • Patrick Brochard,
  • Fleur Delva,
  • Bénédicte Clin,
  • Antoine Gislard,
  • Christophe Paris and
  • Christos Chouaïd
  • + 8 authors+ 3 authors

24 August 2022

Background: The National Lung Screening Trial (NLST) and NELSON study opened the debate on the relevance of lung cancer (LC) screening in subjects exposed to occupational respiratory carcinogens. This analysis reported the incremental cost-effectiven...

(This article belongs to the Special Issue The Role of Cost-Effectiveness Analysis for Patient-Centered Cancer Care in the Era of Precision Medicine)
  • Article
  • Open Access
7 Citations
3,911 Views
13 Pages

A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer

  • Ping-Chih Hsu,
  • Bing-Chen Wu,
  • Chin-Chou Wang,
  • Li-Chung Chiu and ,
  • Chiung-Hsin Chang,
  • Ping-Chi Liu,
  • Chiao-En Wu,
  • Scott Chih-Hsi Kuo,
  • Jia-Shiuan Ju and
  • How-Wen Ko
  • + 8 authors+ 3 authors

29 April 2024

Real-world clinical experience of using anti-programmed death-ligand 1 (PD-L1) immune checkpoint inhibitors (ICIs) combined with chemotherapy in the first-line treatment of extensive-stage small-cell lung cancer (SCLC) patients has rarely been report...

(This article belongs to the Section Vaccination Against Cancer and Chronic Diseases)
  • Review
  • Open Access
71 Citations
6,683 Views
19 Pages

Immune Checkpoint Inhibitors and Cardiac Toxicity in Patients Treated for Non-Small Lung Cancer: A Review

  • Grzegorz Sławiński,
  • Anna Wrona,
  • Alicja Dąbrowska-Kugacka,
  • Grzegorz Raczak and
  • Ewa Lewicka

29 September 2020

Lung cancer is a major cause of cancer-related mortality worldwide, both in men and women. The vast majority of patients are diagnosed with non-small-cell lung cancer (NSCLC, 80–85% of lung cancer cases). Therapeutics named immune checkpoint in...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
2 Citations
1,399 Views
13 Pages

Natural Language Processing-Assisted Incidental Pulmonary Nodule Evaluation Program: Impact on Lung Cancer Outcomes

  • Noa Tamam Shenholz,
  • Keren Hod,
  • Liat Toderis,
  • Noam Fink and ,
  • Arnon Makori,
  • Michael Peer,
  • Evgeni Gershman,
  • Merav A. Ben-David and
  • Elizabeth Dudnik
  • + 4 authors+ 0 author

21 February 2026

Introduction: Early detection and timely treatment (Tx) initiation are critical to improving lung cancer (LC) outcomes. This study assessed the natural language processing (NLP)-assisted incidental pulmonary nodule (IPN) evaluation program, which emp...

(This article belongs to the Special Issue Feature Papers in Section “Cancer and Cancer-Related Research”)
  • Article
  • Open Access
6 Citations
4,217 Views
12 Pages

Lung Support Service: Implementation of a Nationwide Text Message Support Program for People with Chronic Respiratory Disease during the COVID-19 Pandemic

  • Rebecca Raeside,
  • Anna C. Singleton,
  • Allyson Todd,
  • Stephanie R. Partridge and ,
  • Karice K. Hyun,
  • Helen Kulas,
  • Sally L. Wootton,
  • Marita T. Dale,
  • Jennifer A. Alison and
  • Julie Redfern
  • + 9 authors+ 4 authors

Background: COVID-19 pandemic lockdowns led to the closure of most in-person pulmonary rehabilitation programs in Australia. Text message programs are effective for delivering health support to aid the self-management of people with chronic diseases....

(This article belongs to the Special Issue Using Digital Health Technologies to Improve Healthcare Quality)
  • Project Report
  • Open Access
7 Citations
3,609 Views
9 Pages

The Lung Health Ambassador Program: A Community-Engagement Initiative Focusing on Pulmonary-Related Health Issues and Disparities Regarding Tobacco Use

  • Panagis Galiatsatos,
  • Eliza Judge,
  • Rachelle Koehl,
  • Marcella Hill and ,
  • Olivia Veira,
  • Nadia Hansel,
  • Michelle Eakin and
  • Meredith McCormack
  • + 3 authors+ 0 author

Introduction: Educational campaigns have the potential to inform at risk populations about key issues relevant to lung health and to facilitate active engagement promoting healthy behaviors and risk prevention. We developed a community-based educatio...

(This article belongs to the Section Environmental Health)
  • Review
  • Open Access
142 Citations
20,616 Views
25 Pages

Artificial Intelligence in Lung Cancer Screening: The Future Is Now

  • Michaela Cellina,
  • Laura Maria Cacioppa,
  • Maurizio Cè,
  • Vittoria Chiarpenello and ,
  • Marco Costa,
  • Zakaria Vincenzo,
  • Daniele Pais,
  • Maria Vittoria Bausano,
  • Nicolò Rossini and
  • Chiara Floridi
  • + 6 authors+ 1 author

30 August 2023

Lung cancer has one of the worst morbidity and fatality rates of any malignant tumour. Most lung cancers are discovered in the middle and late stages of the disease, when treatment choices are limited, and patients’ survival rate is low. The ai...

(This article belongs to the Special Issue Advances in Oncological Imaging)
  • Article
  • Open Access
4 Citations
3,702 Views
11 Pages

17 February 2024

Introduction: The access and compliance of patients with interstitial lung diseases (ILDs) to exercise programs (EPs) remain challenges. Objectives: We assessed the dropout rate, intervention completion, compliance with data acquisition and submissio...

(This article belongs to the Special Issue Current Advances in Interstitial Lung Diseases)
  • Systematic Review
  • Open Access
80 Citations
11,033 Views
23 Pages

Systematic Review of Lung Cancer Screening: Advancements and Strategies for Implementation

  • Daniela Amicizia,
  • Maria Francesca Piazza,
  • Francesca Marchini,
  • Matteo Astengo and ,
  • Federico Grammatico,
  • Alberto Battaglini,
  • Irene Schenone,
  • Camilla Sticchi,
  • Rosa Lavieri and
  • Filippo Ansaldi
  • + 7 authors+ 2 authors

Lung cancer is the leading cause of cancer-related deaths in Europe, with low survival rates primarily due to late-stage diagnosis. Early detection can significantly improve survival rates, but lung cancer screening is not currently implemented in It...

  • Article
  • Open Access
7 Citations
3,094 Views
15 Pages

Enhanced Recovery Pathway in Lung Resection Surgery: Program Establishment and Results of a Cohort Study Encompassing 1243 Consecutive Patients

  • Yen-Lan Nguyen,
  • Elena Maiolino,
  • Vincent De Pauw,
  • Mathilde Prieto and ,
  • Antonio Mazzella,
  • Jean-Baptiste Peretout,
  • Agnès Dechartres,
  • Christophe Baillard,
  • Antonio Bobbio and
  • Marco Alifano
  • + 6 authors+ 1 author

29 March 2022

Introduction: In spite of increasing diffusion, Enhanced Recovery Pathways (ERP) have been scarcely assessed in large scale programs of lung cancer surgery. The aim of this study was auditing our practice. Methods: A two-step audit program was establ...

(This article belongs to the Special Issue New Treatments of Lung Cancer in the Era of Patient and Tumor Targeted Therapies)
  • Article
  • Open Access
2 Citations
3,302 Views
14 Pages

First-Line Chemoimmunotherapy versus Sequential Platinum-Based Chemotherapy Followed by Immunotherapy in Patients with Non-Small Cell Lung Cancer with ≤49% Programmed Death-Ligand 1 Expression: A Real-World Multicenter Retrospective Study

  • Keiko Tanimura,
  • Takayuki Takeda,
  • Nobutaka Kataoka,
  • Akihiro Yoshimura and ,
  • Kentaro Nakanishi,
  • Yuta Yamanaka,
  • Hiroshige Yoshioka,
  • Ryoichi Honda,
  • Kiyoaki Uryu and
  • Koichi Takayama
  • + 16 authors+ 11 authors

14 October 2023

Background: The long overall survival (OS) observed among patients with non-small cell lung cancer (NSCLC) with high programmed death-ligand 1 (PD-L1) expression in chemoimmunotherapy (CIT) groups in previous phase III trials suggests the limited eff...

(This article belongs to the Special Issue Immunotherapy with Checkpoint Inhibitors for Non-small Cell Lung Cancer)
  • Article
  • Open Access
41 Citations
7,883 Views
17 Pages

Sequential Blockade of PD-1 and PD-L1 Causes Fulminant Cardiotoxicity—From Case Report to Mouse Model Validation

  • Shin-Yi Liu,
  • Wen-Chien Huang,
  • Hung-I Yeh,
  • Chun-Chuan Ko and ,
  • Hui-Ru Shieh,
  • Chung-Lieh Hung,
  • Tung-Ying Chen and
  • Yu-Jen Chen
  • + 3 authors+ 0 author

24 April 2019

The combined administration of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors might be considered as a treatment for poorly responsive cancer. We report a patient with brain metastatic lung adenocarcinoma in whom...

(This article belongs to the Special Issue Immunotherapy, Tumor Microenvironment and Survival Signaling)
  • Article
  • Open Access
712 Views
12 Pages

Clinical Characteristics and Outcomes of Anti-MDA5 Antibody-Associated Interstitial Lung Disease: A Single-Center Retrospective Cohort Study from an Integrated Advanced Lung Disease and Lung Transplant Program in the US

  • Shambhu Aryal,
  • Shourjo Chakravorty,
  • Ho Cheol Kim,
  • Ashima Malik and ,
  • Pragya Singh,
  • Ramona Raya,
  • Oksana A. Shlobin,
  • Christopher S. King,
  • Steven D. Nathan and
  • Zein Kattih
  • + 5 authors+ 0 author

1 October 2026

Background/Objectives: Anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody is associated with dermatomyositis/clinically amyopathic dermatomyositis and a high risk of rapidly progressive interstitial lung disease (RP-ILD). Methods: W...

(This article belongs to the Special Issue Clinical Challenges and Future Directions of Interstitial Lung Disease)
  • Article
  • Open Access
19 Citations
6,357 Views
20 Pages

Thermal Liquid Biopsy (TLB): A Predictive Score Derived from Serum Thermograms as a Clinical Tool for Screening Lung Cancer Patients

  • Alberto Rodrigo,
  • Jorge L. Ojeda,
  • Sonia Vega,
  • Oscar Sanchez-Gracia and ,
  • Angel Lanas,
  • Dolores Isla,
  • Adrian Velazquez-Campoy and
  • Olga Abian
  • + 3 authors+ 0 author

19 July 2019

Risk population screening programs are instrumental for advancing cancer management and reducing economic costs of therapeutic interventions and the burden of the disease, as well as increasing the survival rate and improving the quality of life for...

(This article belongs to the Special Issue Liquid Biopsy for Cancer)
  • Article
  • Open Access
5 Citations
3,662 Views
8 Pages

Assessment of Calcium Score Cutoff Point for Clinically Significant Aortic Stenosis on Lung Cancer Screening Program Low-Dose Computed Tomography—A Cross-Sectional Analysis

  • Kaja Klein-Awerjanow,
  • Witold Rzyman,
  • Robert Dziedzic,
  • Jadwiga Fijalkowska and ,
  • Piotr Spychalski,
  • Edyta Szurowska and
  • Marcin Fijalkowski
  • + 2 authors+ 0 author

Low-dose computed tomography (LDCT) is predominantly applied in lung cancer screening programs. Tobacco smoking is the main risk factor for developing lung cancer but is also common for cardiovascular diseases, including aortic stenosis (AS). Consequ...

(This article belongs to the Special Issue Cardiothoracic Imaging: Diagnostics and Modern Techniques)
  • Article
  • Open Access
4 Citations
987 Views
7 Pages

Pulmonary Prevention Program in the Proszowice County: Description and Results

  • Wojciech Skucha,
  • Filip Mejza,
  • Paweł Nastałek and
  • Zbigniew Doniec

30 October 2017

Introduction: In the Proszowice county, both lung cancer and chronic obstructive pulmonary disease (COPD) are more common in comparison with other regions of Poland. The purpose of this paper was to provide a report on a prevention program carried ou...

  • Case Report
  • Open Access
1 Citations
3,084 Views
7 Pages

Programmed Death-Ligand 1-Positive Squamous Cell Carcinoma Spontaneously Regressed after Percutaneous Needle Biopsy

  • Masayuki Sasahara,
  • Hiroki Takahashi,
  • Takashi Ohchi,
  • Naohiro Nomura and ,
  • Kentaro Kodama,
  • Kimiyuki Ikeda,
  • Hirotaka Nishikiori,
  • Kenzo Okamoto and
  • Hirofumi Chiba
  • + 4 authors+ 0 author

22 March 2023

Spontaneous lung cancer regression is a very rare course of disease. A 60-year-old male patient was admitted to our hospital with pneumonia and a 19 mm-sized nodule shadow in the S4 of the left lung on chest computed tomography (CT). A percutaneous n...

(This article belongs to the Section Pulmonology)
  • Article
  • Open Access
2,172 Views
16 Pages

Factors Influencing the Attrition Rate of a 10-Week Multimodal Rehabilitation Program in Patients After Lung Transplant: A Neural Network Analysis

  • Vanesa Dávalos-Yerovi,
  • Dolores Sánchez-Rodríguez,
  • Alba Gómez-Garrido,
  • Patricia Launois and ,
  • Marta Tejero-Sánchez,
  • Vicenta Pujol-Blaya,
  • Yulibeth G. Curbelo,
  • Owen Donohoe and
  • Ester Marco
  • + 4 authors+ 0 author

10 November 2024

Background/Objectives: Despite the effectiveness of exercise and nutritional interventions to improve aerobic capacity and quality of life in lung transplant (LT) recipients, their compliance is low. Strategies to reduce the high attrition rate (part...

(This article belongs to the Section Chronic Care)
  • Article
  • Open Access
21 Citations
7,550 Views
16 Pages

Effects of a Multicomponent Exercise Program in Older Adults with Non-Small-Cell Lung Cancer during Adjuvant/Palliative Treatment: An Intervention Study

  • Ilem D. Rosero,
  • Robinson Ramírez-Vélez,
  • Nicolas Martínez-Velilla,
  • Bernardo Abel Cedeño-Veloz and ,
  • Idoia Morilla and
  • Mikel Izquierdo
  • + 1 author+ 0 author

21 March 2020

Clinical intervention studies support the efficacy and safety of exercise programs as a treatment modality for non-small-cell lung cancer (NSCLC) during adjuvant/palliative treatment, but the effectiveness of real-world oncogeriatric services is yet...

(This article belongs to the Special Issue Cancer Rehabilitation and Survivorship)
  • Article
  • Open Access
2 Citations
3,323 Views
19 Pages

Influence of Donor-Specific Characteristics on Cytokine Responses in H3N2 Influenza A Virus Infection: New Insights from an Ex Vivo Model

  • Chung-Guei Huang,
  • Ming-Ju Hsieh,
  • Yi-Cheng Wu,
  • Po-Wei Huang and ,
  • Ya-Jhu Lin,
  • Kuo-Chien Tsao,
  • Shin-Ru Shih and
  • Li-Ang Lee
  • + 3 authors+ 0 author

11 October 2024

Influenza A virus (IAV) is known for causing seasonal epidemics ranging from flu to more severe outcomes like pneumonia, cytokine storms, and acute respiratory distress syndrome. The innate immune response and inflammasome activation play pivotal rol...

(This article belongs to the Special Issue Roles of Inflammasomes in Inflammatory Responses and Human Diseases)
  • Article
  • Open Access
3 Citations
1,847 Views
8 Pages

Effectiveness of Osimertinib in Patients with Lung Adenocarcinoma in Clinical Practice—The Expanded Drug Access Program in Poland

  • Magdalena Knetki-Wróblewska,
  • Dariusz M. Kowalski,
  • Grzegorz Czyżewicz,
  • Maciej Bryl and ,
  • Anna Wrona,
  • Rafał Dziadziuszko,
  • Robert Kieszko,
  • Janusz Milanowski,
  • Daria Świniuch and
  • Maciej Krzakowski
  • + 7 authors+ 2 authors

18 July 2020

Introduction: Osimertinib is a third-generation, irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that has demonstrated efficacy in the treatment of EGFR-mutant non-small-cell lung cancer (NSCLC) in prospective clinical...

  • Review
  • Open Access
30 Citations
7,864 Views
12 Pages

Radiation Exposure to Low-Dose Computed Tomography for Lung Cancer Screening: Should We Be Concerned?

  • Chiara Pozzessere,
  • Christophe von Garnier and
  • Catherine Beigelman-Aubry

24 January 2023

Lung cancer screening (LCS) programs through low-dose Computed Tomography (LDCT) are being implemented in several countries worldwide. Radiation exposure of healthy individuals due to prolonged CT screening rounds and, eventually, the additional exam...

(This article belongs to the Special Issue Radiation Protection Opportunities in Medical Imaging)
  • Article
  • Open Access
76 Citations
6,012 Views
16 Pages

PD-L1 Induction by Cancer-Associated Fibroblast-Derived Factors in Lung Adenocarcinoma Cells

  • Chihiro Inoue,
  • Yasuhiro Miki,
  • Ryoko Saito,
  • Shuko Hata and ,
  • Jiro Abe,
  • Ikuro Sato,
  • Yoshinori Okada and
  • Hironobu Sasano
  • + 3 authors+ 0 author

27 August 2019

Cancer-associated fibroblasts (CAFs) exert various effects upon biological behaviours of cancer. In this study, we examined the correlation of CAFs with the intra-tumoural immune system in the lung adenocarcinoma microenvironment. We studied 27 and 1...

  • Article
  • Open Access
445 Views
19 Pages

16 September 2026

Background: Donation after circulatory death (DCD) and donation after brain death (DBD) donor lungs are widely used in lung transplantation yet managed as equivalent with respect to ischemia–reperfusion injury (IRI), despite fundamentally diffe...

(This article belongs to the Section Bioinformatics)
  • Article
  • Open Access
3 Citations
2,894 Views
12 Pages

The Role of Native T1 and T2 Mapping Times in Identifying PD-L1 Expression and the Histological Subtype of NSCLCs

  • Chandra Bortolotto,
  • Gaia Messana,
  • Antonio Lo Tito,
  • Giulia Maria Stella and ,
  • Alessandra Pinto,
  • Chiara Podrecca,
  • Riccardo Bellazzi,
  • Alessia Gerbasi,
  • Francesco Agustoni and
  • Lorenzo Preda
  • + 10 authors+ 5 authors

20 June 2023

We investigated the association of T1/T2 mapping values with programmed death-ligand 1 protein (PD-L1) expression in lung cancer and their potential in distinguishing between different histological subtypes of non-small cell lung cancers (NSCLCs). Th...

(This article belongs to the Special Issue PD-1/PD-L1 Immune Checkpoint Therapy: From Predictive Biomarkers to Noninvasive Imaging)
  • Article
  • Open Access
36 Citations
3,928 Views
15 Pages

Prognostic Nutritional Index and Lung Immune Prognostic Index as Prognostic Predictors for Combination Therapies of Immune Checkpoint Inhibitors and Cytotoxic Anticancer Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer

  • Satomi Tanaka,
  • Junji Uchino,
  • Takashi Yokoi,
  • Takashi Kijima and ,
  • Yasuhiro Goto,
  • Yoshifumi Suga,
  • Yuki Katayama,
  • Ryota Nakamura,
  • Kenji Morimoto and
  • Koichi Takayama
  • + 25 authors+ 20 authors

Combination therapy with immune checkpoint inhibitors and cytotoxic chemotherapies (chemoimmunotherapy) is associated with significantly better survival outcomes than cytotoxic chemotherapies alone in patients with advanced non-small cell lung cancer...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Article
  • Open Access
1 Citations
1,330 Views
10 Pages

Pulmonary Function Among COVID-19 Patients in Home Isolation Program

  • Narongkorn Saiphoklang,
  • Pitchayapa Ruchiwit,
  • Apichart Kanitsap,
  • Pichaya Tantiyavarong and ,
  • Pasitpon Vatcharavongvan,
  • Srimuang Palungrit,
  • Kanyada Leelasittikul,
  • Apiwat Pugongchai and
  • Orapan Poachanukoon
  • + 4 authors+ 0 author

Background: Patients with mild coronavirus disease 2019 (COVID-19) are usually managed in an outpatient setting. Pulmonary functions in this setting have not been explored. This study aimed to determine abnormal lung functions in COVID-19 patients un...

(This article belongs to the Section Pneumology and Respiratory Diseases)
  • Article
  • Open Access
11 Citations
3,113 Views
12 Pages

γH2AX, a DNA Double-Strand Break Marker, Correlates with PD-L1 Expression in Smoking-Related Lung Adenocarcinoma

  • Eiko Sakurai,
  • Hisato Ishizawa,
  • Yuka Kiriyama,
  • Ayano Michiba and ,
  • Yasushi Hoshikawa and
  • Tetsuya Tsukamoto
  • + 1 author+ 0 author

In recent years, the choice of immune checkpoint inhibitors (ICIs) as a treatment based on high expression of programmed death-ligand 1 (PD-L1) in lung cancers has been increasing in prevalence. The high expression of PD-L1 could be a predictor of IC...

(This article belongs to the Special Issue Inflammation and Cancer 2021)
  • Review
  • Open Access
16 Citations
4,853 Views
23 Pages

Configuring Therapeutic Aspects of Immune Checkpoints in Lung Cancer

  • Avinash Khadela,
  • Vivek P. Chavda,
  • Humzah Postwala,
  • Ramya Ephraim and ,
  • Vasso Apostolopoulos and
  • Yesha Shah
  • + 1 author+ 0 author

16 January 2023

Immune checkpoints are unique components of the body’s defense mechanism that safeguard the body from immune responses that are potent enough to harm healthy body cells. When proteins present on the surface of T cells recognize and bind to the...

(This article belongs to the Special Issue Checkpoint Markers and Cancer Microenvironment: What Do We Know?)
  • Article
  • Open Access
1 Citations
1,798 Views
10 Pages

Changes in Lung Ultrasound in Systemic Sclerosis Before and After Rehabilitation: A Comparative Study Between People with and Without Interstitial Lung Disease

  • Samantha Gomes de Alegria,
  • Matheus Mello da Silva,
  • Jéssica Gabriela Messias Oliveira,
  • Beatriz Luiza Pinheiro Alves de Azevedo and ,
  • Nathália Alves de Oliveira Saraiva,
  • Isabelle da Nóbrega Ferreira,
  • Joana Acar Silva,
  • Thiago Thomaz Mafort,
  • Cláudia Henrique da Costa and
  • Agnaldo José Lopes
  • + 5 authors+ 0 author

There is limited research on the impact of a physiotherapy-guided rehabilitation program (PGRP) on lung structure in systemic sclerosis (SSc). Lung ultrasound (LUS) has been used for over a decade to identify interstitial lung disease associated with...

  • Review
  • Open Access
74 Citations
16,330 Views
23 Pages

First line Immunotherapy for Non-Small Cell Lung Cancer

  • Nicola J. Nasser,
  • Miguel Gorenberg and
  • Abed Agbarya

8 November 2020

Immunotherapy for non-small cell lung cancer (NSCLC) is incorporated increasingly in first line treatments protocols. Multiple phase 3 studies have tested different medications targeting programmed death receptor 1 (PD-1), programmed death-ligand 1 (...

(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)
  • Article
  • Open Access
2 Citations
1,798 Views
7 Pages

Implementing A One-Day Testing Model Improves Timeliness of Workup for Patients with Lung Cancer

  • M.A. Gulak,
  • C. Bornais,
  • S. Shin,
  • L. Murphy and ,
  • J. Smylie,
  • J.R. Pantarotto,
  • M. Fung-Kee-Fung and
  • D.E. Maziak
  • + 3 authors+ 0 author

1 October 2019

Background: Patients with lung cancer often experience stressful delays throughout the diagnostic phase of care. To address that situation, our multidisciplinary team created a “Navigation Day,” during which patients partake in a single-day visit tha...

  • Article
  • Open Access
5 Citations
3,146 Views
16 Pages

A Comprehensive Analysis of Programmed Cell Death-Associated Genes for Tumor Microenvironment Evaluation Promotes Precise Immunotherapy in Patients with Lung Adenocarcinoma

  • Yunxi Huang,
  • Wenhao Ouyang,
  • Zehua Wang,
  • Hong Huang and ,
  • Qiyun Ou,
  • Ruichong Lin,
  • Yunfang Yu and
  • Herui Yao
  • + 3 authors+ 0 author

6 March 2023

Immune checkpoint inhibitors (ICIs) represent a new hot spot in tumor therapy. Programmed cell death has an important role in the prognosis. We explore a programmed cell death gene prognostic model associated with survival and immunotherapy predictio...

(This article belongs to the Section Personalized Therapy and Drug Delivery)
  • Article
  • Open Access
2 Citations
3,260 Views
16 Pages

Detection of Potential Mutated Genes Associated with Common Immunotherapy Biomarkers in Non-Small-Cell Lung Cancer Patients

  • Lei Cao,
  • Zhili Cao,
  • Hongsheng Liu,
  • Naixin Liang and ,
  • Zhongxing Bing,
  • Caijuan Tian and
  • Shanqing Li
  • + 2 authors+ 0 author

15 August 2022

Microsatellite instability (MSI), high tumor mutation burden (TMB-H) and programmed cell death 1 ligand 1 (PD-L1) expression are hot biomarkers related to the improvement of immunotherapy response. Two cohorts of non-small-cell lung cancer (NSCLC) we...

  • Review
  • Open Access
10 Citations
4,872 Views
18 Pages

Comprehensive Review: Unveiling the Pro-Oncogenic Roles of IL-1ß and PD-1/PD-L1 in NSCLC Development and Targeting Their Pathways for Clinical Management

  • Dani Ran Castillo,
  • Won Jin Jeon,
  • Daniel Park,
  • Bryan Pham and ,
  • Chieh Yang,
  • Bowon Joung,
  • Jin Hyun Moon,
  • Jae Lee,
  • Esther G. Chong and
  • Saied Mirshahidi
  • + 9 authors+ 4 authors

In the past decade, targeted therapies for solid tumors, including non-small cell lung cancer (NSCLC), have advanced significantly, offering tailored treatment options for patients. However, individuals without targetable mutations pose a clinical ch...

(This article belongs to the Special Issue Targeted Therapies and Molecular Methods in Cancer, 2nd Edition)
  • Communication
  • Open Access
21 Citations
6,601 Views
13 Pages

The Risks and Benefits of Immune Checkpoint Blockade in Anti-AChR Antibody-Seropositive Non-Small Cell Lung Cancer Patients

  • Koichi Saruwatari,
  • Ryo Sato,
  • Shunya Nakane,
  • Shinya Sakata and ,
  • Koutaro Takamatsu,
  • Takayuki Jodai,
  • Remi Mito,
  • Yuko Horio,
  • Sho Saeki and
  • Takuro Sakagami
  • + 6 authors+ 1 author

24 January 2019

Background: Anti-programmed cell death 1 (PD-1) monoclonal antibodies (Abs) unleash an immune response to cancer. However, a disruption of the immune checkpoint function by blocking PD-1/PD-ligand 1(PD-L1) signaling may trigger myasthenia gravis (MG)...

(This article belongs to the Special Issue Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers)

of 27